IDO1 and chronic obstructive pulmonary disease: Elevated levels of these inflammatory mediators and decreased levels of anti-inflammatory and immune-regulatory mediators such as IL-10 and indoleamine 2,3-dioxygenase (IDO) (29) further boost disease progression in COPD.